Literature DB >> 21349101

Cell biology and immunology of malaria.

Julius Clemence Hafalla1, Olivier Silvie, Kai Matuschewski.   

Abstract

Malaria is a vector-borne infectious disease caused by unicellular parasites of the genus Plasmodium. These obligate intracellular parasites have the unique capacity to infect and replicate within erythrocytes, which are terminally differentiated host cells that lack antigen presentation pathways. Prior to the cyclic erythrocytic infections that cause the characteristic clinical symptoms of malaria, the parasite undergoes an essential and clinically silent expansion phase in the liver. By infecting privileged host cells, employing programs of complex life stage conversions and expressing varying immunodominant antigens, Plasmodium parasites have evolved mechanisms to downmodulate protective immune responses against ongoing and even future infections. Consequently, anti-malaria immunity develops only gradually over many years of repeated and multiple infections in endemic areas. The identification of immune correlates of protection among the abundant non-protective host responses remains a research priority. Understanding the molecular and immunological mechanisms of the crosstalk between the parasite and the host is a prerequisite for the rational discovery and development of a safe, affordable, and protective anti-malaria vaccine.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21349101     DOI: 10.1111/j.1600-065X.2010.00988.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  45 in total

Review 1.  Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.

Authors:  Peter D Crompton; Jacqueline Moebius; Silvia Portugal; Michael Waisberg; Geoffrey Hart; Lindsey S Garver; Louis H Miller; Carolina Barillas-Mury; Susan K Pierce
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

Review 2.  Platform for Plasmodium vivax vaccine discovery and development.

Authors:  Sócrates Herrera Valencia; Diana Carolina Rodríguez; Diana Lucía Acero; Vanessa Ocampo; Myriam Arévalo-Herrera
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 3.  Plasmodium Sporozoite Biology.

Authors:  Friedrich Frischknecht; Kai Matuschewski
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

4.  A new therapeutic strategy for malaria: targeting T cell exhaustion.

Authors:  Gordon J Freeman; Arlene H Sharpe
Journal:  Nat Immunol       Date:  2012-01-19       Impact factor: 25.606

5.  Nonspecific CD8+ T Cells and Dendritic Cells/Macrophages Participate in Formation of CD8+ T Cell-Mediated Clusters against Malaria Liver-Stage Infection.

Authors:  Masoud Akbari; Kazumi Kimura; Ganchimeg Bayarsaikhan; Daisuke Kimura; Mana Miyakoda; Smriti Juriasingani; Masao Yuda; Rogerio Amino; Katsuyuki Yui
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

Review 6.  Towards genome-wide experimental genetics in the in vivo malaria model parasite Plasmodium berghei.

Authors:  Joachim M Matz; Taco W A Kooij
Journal:  Pathog Glob Health       Date:  2015-03-19       Impact factor: 2.894

Review 7.  Iron metabolism and the innate immune response to infection.

Authors:  Erin E Johnson; Marianne Wessling-Resnick
Journal:  Microbes Infect       Date:  2011-10-20       Impact factor: 2.700

8.  Experimental cerebral malaria develops independently of endothelial expression of intercellular adhesion molecule-1 (icam-1).

Authors:  Theresa N Ramos; Daniel C Bullard; Meghan M Darley; Kristin McDonald; David F Crawford; Scott R Barnum
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

Review 9.  Murine infection models for vaccine development: the malaria example.

Authors:  Kai Matuschewski
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

10.  A novel domain cassette identifies Plasmodium falciparum PfEMP1 proteins binding ICAM-1 and is a target of cross-reactive, adhesion-inhibitory antibodies.

Authors:  Anja Bengtsson; Louise Joergensen; Thomas S Rask; Rebecca W Olsen; Marianne A Andersen; Louise Turner; Thor G Theander; Lars Hviid; Matthew K Higgins; Alister Craig; Alan Brown; Anja T R Jensen
Journal:  J Immunol       Date:  2012-12-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.